TTY Biopharm Company Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 7, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	18,748	20,265	18,102	19,991	20,737	17,107
Market Cap Growth	7.71%	11.95%	-9.45%	-3.60%	21.22%	0.29%
Enterprise Value	17,273	20,278	18,292	20,061	20,686	16,707
Last Close Price	75.40	76.92	65.03	68.73	68.26	53.98
PE Ratio	12.26	13.00	12.49	17.72	18.95	20.56
Forward PE	-	12.86	12.86	14.81	17.45	16.54
PS Ratio	2.88	3.14	3.07	3.63	4.10	3.77
PB Ratio	2.53	2.52	2.41	3.07	3.33	2.97
P/TBV Ratio	3.14	2.97	2.84	3.46	3.84	3.39
P/FCF Ratio	9.84	12.16	14.79	19.85	18.12	14.30
P/OCF Ratio	9.29	11.50	13.42	18.42	16.78	13.62
EV/Sales Ratio	2.65	3.14	3.10	3.64	4.09	3.68
EV/EBITDA Ratio	8.02	10.72	11.52	12.81	14.69	12.82
EV/EBIT Ratio	8.81	11.90	13.12	14.62	16.85	14.65
EV/FCF Ratio	9.06	12.16	14.94	19.92	18.08	13.97
Debt / Equity Ratio	0.07	0.15	0.23	0.29	0.29	0.37
Debt / EBITDA Ratio	0.26	0.64	1.08	1.19	1.28	1.65
Debt / FCF Ratio	0.27	0.73	1.40	1.85	1.58	1.79
Net Debt / Equity Ratio	-0.31	-0.22	-0.18	-0.15	-0.14	-0.08
Net Debt / EBITDA Ratio	-1.17	-0.94	-0.86	-0.61	-0.62	-0.34
Net Debt / FCF Ratio	-1.21	-1.06	-1.12	-0.95	-0.77	-0.38
Asset Turnover	0.57	0.58	0.57	0.56	0.54	0.49
Inventory Turnover	2.12	2.06	2.10	2.08	2.05	1.71
Quick Ratio	1.16	1.72	1.56	1.62	1.35	1.23
Current Ratio	1.71	2.28	2.02	2.08	1.73	1.56
Return on Equity (ROE)	23.94%	21.27%	21.68%	17.56%	18.38%	13.89%
Return on Assets (ROA)	9.83%	9.59%	8.40%	8.81%	8.12%	7.64%
Return on Invested Capital (ROIC)	24.53%	21.37%	19.22%	19.84%	18.02%	15.73%
Return on Capital Employed (ROCE)	22.10%	19.60%	17.40%	18.80%	18.40%	18.30%
Earnings Yield	8.59%	7.69%	8.01%	5.64%	5.28%	4.86%
FCF Yield	10.17%	8.23%	6.76%	5.04%	5.52%	6.99%
Dividend Yield	5.97%	5.85%	6.46%	5.09%	4.98%	5.56%
Payout Ratio	64.82%	66.98%	60.04%	74.91%	68.16%	119.56%
Buyback Yield / Dilution	-5.24%	-0.03%	-0.04%	-0.03%	0.02%	0.00%
Total Shareholder Return	0.73%	5.82%	6.42%	5.06%	5.00%	5.56%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.